X. Zhou

发表

Survival and outcomes of surgical treatment of the elderly NSCLC in China: a retrospective matched cohort study.

G. Jiang, J. Fan, X. J. Wang, 2007, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.

Renal cell carcinoma with X;1 translocation in a child with Klinefelter syndrome.

M. Susin, L. Mehta, A. Yenamandra, 1998, American journal of medical genetics.

Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.

J. Cerhan, A. Zelenetz, J. Friedberg, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

J. Douillard, M. Peeters, J. Wiezorek, 2011, British Journal of Cancer.

Metastasis-free survival is associated with overall survival in men with PSA-recurrent prostate cancer treated with deferred androgen deprivation therapy.

A. Partin, E. Antonarakis, T. Yang, 2013, Annals of oncology : official journal of the European Society for Medical Oncology.

Disease characteristics, treatment patterns, and outcomes of follicular lymphoma in patients 40 years of age and younger: an analysis from the National Lymphocare Study†.

J. Cerhan, A. Zelenetz, J. Friedberg, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

Examination of the follicular lymphoma international prognostic index (FLIPI) in the National LymphoCare study (NLCS): a prospective US patient cohort treated predominantly in community practices.

J. Cerhan, A. Zelenetz, J. Friedberg, 2013 .

Updated overall survival (OS) from extended follow up in ARCHER 1050: A randomized phase III study comparing dacomitinib with gefitinib as first-line therapy for patients (pts) with EGFR mutations

Ying Cheng, T. Mok, K. Wilner, 2019, Annals of Oncology.

Examination of the Follicular Lymphoma International Prognostic Index (FLIPI) in the National LymphoCare Study (NLCS): A U.S. patient cohort treated predominantly in community practices.

J. Cerhan, A. Zelenetz, J. Friedberg, 2011, Journal of Clinical Oncology.

1175OEGFR MUTATION AND SURVIVAL OUTCOMES IN PATIENTS WITH COMPLETELY RESECTED LUNG ADENOCARCINOMA - A MULTIPLE CENTERS, NON-INTERVENTIONAL STUDY (ICAN TRIAL).

Q. Wang, Y. Wu, Y. Liu, 2014, Annals of oncology : official journal of the European Society for Medical Oncology.

P79.02 Updated OS and Time to Second Progression with First-Line Camrelizumab Plus Chemo vs Chemo for Advanced Non-Squamous NSCLC

X. Jiang, J. Fang, F. Wu, 2021 .

OA04.03 A Randomized Phase 3 Study of Camrelizumab plus Chemotherapy as 1st Line Therapy for Advanced/Metastatic Non-Squamous Non-Small Cell Lung Cancer

X. Jiang, J. Fang, C. Zhu, 2019, Journal of Thoracic Oncology.

265O Anlotinib in locally advanced or metastatic radioiodine-refractory differentiated thyroid carcinoma: A randomized, double-blind, multicenter phase II trial

Y. Cheng, J. Qin, J. Zhang, 2020, Annals of Oncology.

Phase I dose-escalation study of the investigational Aurora A kinase (AAK) inhibitor MLN8237 as an enteric-coated tablet (ECT) formulation in patients with nonhematologic malignancies.

R. Kurzrock, D. Hong, H. Fingert, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.